Evidence map›Paper›PMID 18976914›Full record

ArticleCurrent biology : CB2008

Oscillatory phosphorylation of yeast Fus3 MAP kinase controls periodic gene expression and morphogenesis.

Zoe Hilioti, Walid Sabbagh, Saurabh Paliwal, Adriel Bergmann, Marcus D Goncalves, Lee Bardwell, Andre Levchenko

Erratum issuedAbstract read
In one paragraph

Article in Current biology : CB, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Oscillations and bistability in a model of ERK regulation.Journal of mathematical biology · 2019
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Band-pass processing in a GPCR signaling pathway selects for NFAT transcription factor activation.Integrative biology : quantitative biosciences from nano to macro · 2015
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

7 authors.

Zoe HiliotiDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
Walid Sabbagh
Saurabh Paliwal
Adriel Bergmann
Marcus D Goncalves
Lee Bardwell
Andre Levchenko

Funding

TCP5: ACTIVE SITE LABELING REAGENT FOR ACETYLTRANSFERASESU54RR020839 · NCRR · JOHNS HOPKINS UNIVERSITY · PI BOEKE, JEF D · 2004 to 2011
$27.4M
Uncover Strategies Used By Biological SystemsP50GM076516 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LANDER, ARTHUR D · 2007 to 2016
$25.1M
Information tranfer in NF-kappaB and MAPK pathwaysR01GM072024 · NIGMS · YALE UNIVERSITY · PI LEVCHENKO, ANDRE · 2004 to 2019
$3.9M
MAP KINASE CASCADE SIGNAL TRANSMISSION AND SPECIFICITYR01GM060366 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BARDWELL, LEE S · 2000 to 2008
$2.2M
A signal transduction pathway database/modeling systemR33GM069013 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI MJOLSNESS, ERIC D · 2004 to 2006
$1.7M
An Integrative Analysis of MAPK Signaling in Budding YeastR01GM084332 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI LEVCHENKO, ANDRE · 2008 to 2011
$1.2M
Specificity and Spatial Dynamics of Cell Signaling: The*R01GM075309 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI NIE, QING · 2005 to 2008
$1.1M
A signal transduction pathway database/modeling systemR21GM069013 · NIGMS · UNIVERSITY OF CALIFORNIA IRVINE · PI MJOLSNESS, ERIC D · 2003 to 2003
$157k
NCRR NIH HHS RR020839NCRR NIH HHS U54 RR020839NIGMS NIH HHS GM60366NIGMS NIH HHS GM69013NIGMS NIH HHS GM72024NIGMS NIH HHS GM75309NIGMS NIH HHS GM76516NIGMS NIH HHS GM84332NIGMS NIH HHS P50 GM076516NIGMS NIH HHS R01 GM060366NIGMS NIH HHS R01 GM072024NIGMS NIH HHS R01 GM075309NIGMS NIH HHS R01 GM084332NIGMS NIH HHS R21 GM069013NIGMS NIH HHS R33 GM069013
6 · The paper itself

Abstract

Signal-transduction networks can display complex dynamic behavior such as oscillations in the activity of key components [1-6], but it is often unclear whether such dynamic complexity is actually important for the network's regulatory functions [7, 8]. Here, we found that the mitogen-activated protein kinase (MAPK) Fus3, a key regulator of the yeast mating-pheromone response, undergoes sustained oscillations in its phosphorylation and activation state during continuous pheromone exposure. These MAPK activity oscillations led to corresponding oscillations in mating-gene expression. Oscillations in MAPK activity and gene expression required the negative regulator of G protein signaling Sst2 and partially required the MAPK phosphatase Msg5. Peaks in Fus3 activation correlated with periodic rounds of cell morphogenesis, with each peak preceding the formation of an additional mating projection. Preventing projection formation did not eliminate MAPK oscillation, but preventing MAPK oscillation blocked the formation of additional projections. A mathematical model was developed that reproduced several features of the observed oscillatory dynamics. These observations demonstrate a role for MAPK activity oscillation in driving a periodic downstream response and explain how the pheromone signaling pathway, previously thought to desensitize after 1-3 hr, controls morphology changes that continue for a much longer time.

Indexed as

Biological ClocksGene Expression Regulation, FungalMorphogenesisEnzyme ActivationGTPase-Activating ProteinsMitogen-Activated Protein KinasesPhosphorylationProtein Tyrosine PhosphatasesRGS ProteinsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsFUS3 protein, S cerevisiaeGTPase-Activating ProteinsMitogen-Activated Protein KinasesMSG5 protein, S cerevisiaeProtein Tyrosine PhosphatasesRGS ProteinsSaccharomyces cerevisiae ProteinsSST2 protein, S cerevisiae

Identifiers

PMID18976914
PMCPMC2602854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.